Pro Share Advisors LLC I Bio, Inc. Transaction History

Pro Share Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$0.23 - $0.46 $9,320 - $18,640	-40,522 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$0.3 - $0.61 $2,006 - $4,079	-6,687 Reduced 14.16%	40,522 $17,000
Q4 2021 Feb 08, 2022	BUY	$0.55 - $1.04 $10,732 - $20,293	19,513 Added 70.45%	47,209 $25,000
Q3 2021 Nov 12, 2021	SELL	$1.06 - $1.52 $30,072 - $43,122	-28,370 Reduced 50.6%	27,696 $29,000
Q2 2021 Aug 13, 2021	SELL	$1.22 - $1.65 $1,378 - $1,864	-1,130 Reduced 1.98%	56,066 $85,000
Q1 2021 May 14, 2021	BUY	$1.18 - $2.62 $20,404 - $45,305	17,292 Added 43.33%	57,196 $88,000
Q4 2020 Feb 09, 2021	BUY	$1.05 - $2.24 $41,899 - $89,384	39,904 New	39,904 $42,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.